174 related articles for article (PubMed ID: 28647209)
21. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
22. Expression of pyruvate dehydrogenase is an independent prognostic marker in gastric cancer.
Sun XR; Sun Z; Zhu Z; Guan HX; Li CY; Zhang JY; Zhang YN; Zhou H; Zhang HJ; Xu HM; Sun MJ
World J Gastroenterol; 2015 May; 21(17):5336-44. PubMed ID: 25954108
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognosis relevance of COX-2 expression in Tunisian patients with primary gastric adenocarcinoma.
Ben Ayed-Guerfali D; Charfi S; Khabir A; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Cancer Biomark; 2016 Jun; 17(1):67-73. PubMed ID: 27314294
[TBL] [Abstract][Full Text] [Related]
24. FTO expression is associated with the occurrence of gastric cancer and prognosis.
Xu D; Shao W; Jiang Y; Wang X; Liu Y; Liu X
Oncol Rep; 2017 Oct; 38(4):2285-2292. PubMed ID: 28849183
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
Han Y; Lu S; Wen YG; Yu FD; Zhu XW; Qiu GQ; Tang HM; Peng ZH; Zhou CZ
Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
[TBL] [Abstract][Full Text] [Related]
27. High Expression of long non-coding RNA PVT1 predicts metastasis in Han and Uygur Patients with Gastric Cancer in Xinjiang, China.
Ren X; Cao D; Yang L; Li X; Zhang W; Xiao Y; Xi Y; Li F; Li D; Pan Z
Sci Rep; 2019 Jan; 9(1):548. PubMed ID: 30679629
[TBL] [Abstract][Full Text] [Related]
28. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
Shi YX; Ye BL; Hu BR; Ruan XJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
[TBL] [Abstract][Full Text] [Related]
29. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer.
Zhang Z; Wen M; Guo J; Shi J; Wang Z; Tan B; Zhang G; Zheng X; Zhang A
Pathol Res Pract; 2017 Aug; 213(8):929-937. PubMed ID: 28647207
[TBL] [Abstract][Full Text] [Related]
30. DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.
Lee HE; Han N; Kim MA; Lee HS; Yang HK; Lee BL; Kim WH
Pathobiology; 2014; 81(1):25-35. PubMed ID: 23969480
[TBL] [Abstract][Full Text] [Related]
31. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
Kamphues C; Bova R; Bahra M; Klauschen F; Muckenhuber A; Sinn BV; Warth A; Goeppert B; Endris V; Neuhaus P; Weichert W; Stenzinger A
Pancreas; 2015 Mar; 44(2):296-301. PubMed ID: 25423555
[TBL] [Abstract][Full Text] [Related]
32. Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients.
Lee KW; Tsai YS; Chiang FY; Huang JL; Ho KY; Yang YH; Kuo WR; Chen MK; Lin CS
Ann Oncol; 2011 May; 22(5):1088-1093. PubMed ID: 21127011
[TBL] [Abstract][Full Text] [Related]
33. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival.
He XX; Ding L; Lin Y; Shu M; Wen JM; Xue L
J Clin Pathol; 2015 May; 68(5):374-80. PubMed ID: 25731189
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C
Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
[TBL] [Abstract][Full Text] [Related]
35. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
36. GRIK3: A novel oncogenic protein related to tumor TNM stage, lymph node metastasis, and poor prognosis of GC.
Gong B; Li Y; Cheng Z; Wang P; Luo L; Huang H; Duan S; Liu F
Tumour Biol; 2017 Jun; 39(6):1010428317704364. PubMed ID: 28631555
[TBL] [Abstract][Full Text] [Related]
37. Up-regulation of ECT2 is associated with poor prognosis in gastric cancer patients.
Jin Y; Yu Y; Shao Q; Ma Y; Zhang R; Yao H; Xu Y
Int J Clin Exp Pathol; 2014; 7(12):8724-31. PubMed ID: 25674238
[TBL] [Abstract][Full Text] [Related]
38. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
Zhou B; Jing XY; Wu JQ; Xi HF; Lu GJ
Int J Clin Exp Pathol; 2014; 7(12):8893-8. PubMed ID: 25674261
[TBL] [Abstract][Full Text] [Related]
40. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
